The relevance of Tim-3 polymorphisms and F protein to the outcomes of HCV infection

Authors:

Abstract
Hepatitis C virus (HCV) is one of the major causes of liver inflammation. The aim of this study was to investigate the associations of T-cell immunoglobulin and mucin domain-3 (Tim-3) polymorphisms and the alternate reading frame protein (F protein) with the outcomes of HCV infection. Three single-nucleotide polymorphisms (SNPs; rs10053538, rs12186731, and rs13170556) of Tim-3 were genotyped in this study, which included 203 healthy controls, 558 hepatitis C anti-F-positive patients, and 163 hepatitis C anti-F-negative patients. The results revealed that the rs12186731 CT and rs13170556 TC and CC genotypes were significantly less frequent in the anti-F-positive patients [odds ratio (OR) = 0.54, 95 % confidence interval (CI) = 0.35–0.83, p = 0.005; OR = 0.26, 95 % CI = 0.18–0.39, p < 0.001; and OR = 0.19, 95 % CI = 0.10–0.35, p < 0.001, respectively), and the rs13170556 TC genotype was more frequent in the chronic HCV (CHC) patients (OR = 1.70, 95 % CI = 1.20–2.40, p = 0.002). The combined analysis of the rs12186731 CT and rs13170556 TC/CC genotypes revealed a locus-dosage protective effect in the anti-F-positive patients (OR = 0.22, 95 % CI = 0.14–0.33, p trend < 0.001). Stratified analyses revealed that the frequencies of the rs12186731 (CT + TT) genotypes were significantly lower in the older (OR = 0.31, 95 % CI = 0.15–0.65, p = 0.002) and female (OR = 0.30, 95 % CI = 0.17–0.52, p < 0.001) subgroups, and rs13170556 (TC + CC) genotypes exhibited the same effect in all subgroups (all p < 0.001) in the anti-F antibody generations. Moreover, the rs13170556 (TC + CC) genotypes were significantly more frequent in the younger (OR = 1.86, 95 % CI = 1.18–2.94, p = 0.007) and female (OR = 2.38, 95 % CI = 1.48–3.83, p < 0.001) subgroups of CHC patients. These findings suggest that the rs12186731 CT and rs13170556 TC/CC genotypes of Tim-3 provide potential protective effects with the F protein in the outcomes of HCV infection and that these effects are related to sex and age.
Funding Information
  • National Natural Science Foundation of China (CN) (81172724, 81573213)
  • National Natural Science Foundation of China (CN) (81172724, 81573213)
  • Natural Science Foundation of Jiangsu Province, China (BK20151089, BL2013021)
  • Natural Science Foundation of Jiangsu Province, China (BK20151089, BL2013021)
  • Tian Qing Liver Disease Research Fund of Chinese Hepatitis Foundation (CFHPC20132071)

This publication has 42 references indexed in Scilit: